BIAFVSNXTC• 7 Days (Normalized)
BIAF vs NXTC (bioAffinity Technologies Inc. vs NextCure Inc.)
Showing Closing Date Range from Sep, 04 to Sep, 11, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BIAF Performance $7.95
-47.94%
bioAffinity Technologies Inc.
Normalized Baseline0.00%
NXTC Performance $7
-10.49%
NextCure Inc.
Normalized Baseline0.00%
Alpha Spread Margin NXTC LEADS
-37.45%
NXTC outperforming by 37.45%
BIAFNXTC
Spread Trajectory7 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BIAF NXTC
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(5 dates)
| Date | BIAF Price | BIAF Gain (%) | NXTC Price | NXTC Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 11, 2026 | $7.95 | -47.94% | $7.00 | -10.49% | -37.45% |
| Sep 10, 2026 | $9.39 | -38.51% | $7.31 | -6.52% | -31.99% |
| Sep 09, 2026 | $10.50 | -31.24% | $8.07 | +3.20% | -34.44% |
| Sep 08, 2026 | $8.93 | -41.52% | $8.42 | +7.67% | -49.19% |
| Sep 04, 2026 | $15.27 | +0.00% | $7.82 | +0.00% | +0.00% |